GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,490.00p
   
  • Change Today:
    -16.00p
  • 52 Week High: 1,722.50
  • 52 Week Low: 1,459.00
  • Currency: UK Pounds
  • Shares Issued: 4,918.48m
  • Volume: 7,080,333
  • Market Cap: 73,285m
  • RiskGrade: 72

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (18-08-2017)

6 Month Chart

Financials

Latest F'cast
Div Yield 5.4% 0.0%
Div Cover 1.3 n/a
Op Mrgn 9.3% n/a
ROCE 162.9%  
Latest F'cast
P/E 14.6 n/a
PEG 0.4 n/a
Pr/Revenue 2.6 n/a
Pr/Book 14.8  
Latest F'cast
Revenue 16.6% n/a
PBT -81.6% n/a
EPS 35.3% n/a
DPS n/a n/a

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 26,431.00 6,600.00 111.40p 12.0 n/a -2% 74.00p 5.5%
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 10-Aug-2017 16:43 RNS
Director/PDMR Shareholding 10-Aug-2017 10:50 RNS
Base prospectus re £15bn EMTN programme 04-Aug-2017 09:06 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
09-Aug-17 Buy Patrick Vallance 1,518.61p 8 121.49
09-Aug-17 Transfer From Dominic Redfern 0.000p 8 0.00
09-Aug-17 Transfer From Simon Dingemans 0.000p 8 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,490.00p
Change Today -16.00p
% Change -1.06 %
52 Week High 1,722.50
52 Week Low 1,459.00
Volume 7,080,333
Shares Issued 4,918.48m
Market Cap 73,285m
RiskGrade 72

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.78% below the market average73.78% below the market average73.78% below the market average73.78% below the market average73.78% below the market average
75.86% below the sector average75.86% below the sector average75.86% below the sector average75.86% below the sector average75.86% below the sector average
Price Trend
45.73% below the market average45.73% below the market average45.73% below the market average45.73% below the market average45.73% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
7.86% below the market average7.86% below the market average7.86% below the market average7.86% below the market average7.86% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Growth
9.12% above the market average9.12% above the market average9.12% above the market average9.12% above the market average9.12% above the market average
22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 10-Aug-17 11-May-17
Paid 12-Oct-17 13-Jul-17
Amount 19.00p 19.00p

Trades for 18-Aug-2017

Time Volume / Share Price
17:03 2,800 @ 1,487.53p
17:03 11,713 @ 1,490.64p
17:03 20,510 @ 1,488.87p
17:02 118,678 @ 1,490.47p
17:02 28,816 @ 1,490.65p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page